Prevent counterfeit proliferation

Mydawa platformAlthough the pharmaceutical industry has succeeded in providing access to safe medicines, counterfeiting poses a life-threatening risk to that success. What makes the threat urgent is the expected rise in chronic diseases such as cancer, diabetes and heart diseases.

Pharma industry welcomes new medicines regulator

Pharmaceutical capsules Government has signed the Medicines and Related Substances Amendment Act (2008) marking the official existence of the much-anticipated South African Health Products Regulatory Authority (SAHPRA) as of today. The body is now in preparation to officially take over operations from the Medicines Control Council (MCC).

Afriplex acquires Edelweiss Pharmaceuticals

Tablet manufacturing at Afriplex’s facility in Cape TownAfriplex recently acquired the business of Edelweiss Pharmaceuticals and is in the process of taking over the manufacturing of all solid dosage forms, namely tablets and capsules.

NAPM rebrands as Generic and Biosimilar Medicines Southern Africa

Herman Grobler, chairman of GBM, and Vivian Frittelli, CEO of GBM, revealing the new branding and logo for Generic and Biosimilar Medicines Southern AfricaThe National Association of Pharmaceutical Manufacturers (NAPM) revealed its new branding and name change to Generic and Biosimilar Medicines Southern Africa (GBM) on 11 May. The association – which was launched 40 years ago – continues to keep pace with global industry developments.

Novartis ranks third in 2016 Access to Medicine Index

The logo of NovartisNovartis has moved up one spot on the Access to Medicine Index, ranking third in the 2016 Index. This is in recognition of its efforts to improve worldwide access to healthcare.

Would you like to receive our FREE e-newsletter?

* indicates required